Page last updated: 2024-11-07

methylprednisolone acetate and Ochronosis

methylprednisolone acetate has been researched along with Ochronosis in 1 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Ochronosis: The yellowish discoloration of connective tissue due to deposition of HOMOGENTISIC ACID (a brown-black pigment). This is due to defects in the metabolism of PHENYLALANINE and TYROSINE. Ochronosis occurs in ALKAPTONURIA, but has also been associated with exposure to certain chemicals (e.g., PHENOL, trinitrophenol, BENZENE DERIVATIVES).

Research Excerpts

ExcerptRelevanceReference
"Ochronosis is a rare genetic metabolic disorder resulting from a constitutional lack of homogentisic acid oxidase and subsequent accumulation of its substrate causing destruction of connective tissues with various systemic abnormalities."1.36[Acute bilateral shoulder pain as initial presentation of ochronosis: a case report and literature review]. ( Babic-Naglic, D; Curkovic, B; Laktasic-Zerjavic, N; Potocki, K; Prutki, M; Soldo-Juresa, D, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Laktasic-Zerjavic, N1
Curkovic, B1
Babic-Naglic, D1
Potocki, K1
Prutki, M1
Soldo-Juresa, D1

Other Studies

1 other study available for methylprednisolone acetate and Ochronosis

ArticleYear
[Acute bilateral shoulder pain as initial presentation of ochronosis: a case report and literature review].
    Zeitschrift fur Rheumatologie, 2010, Volume: 69, Issue:5

    Topics: Combined Modality Therapy; Female; Humans; Injections, Intra-Articular; Methylprednisolone; Methylpr

2010